SLC13A5-IN-1, 10 mM in DMSON-[(4-chlorophenyl)methyl]-1-(3,5-dichlorobenzen esulfonyl)piperidine-4-carboxamide4-Piperidinecarboxamide, N-[(4-chlorophenyl)methyl]-1-[(3,5-dichlorophenyl)sulfonyl]-hSLC3A5,metabolic,SLC-13A5-IN-1,SLC13A5IN1,Inhibitor,Citrate,SLC13A5,cardiovascular,inhibit,disease,Sodium Channel,Uptake,Na channels,Na+ channels,SLC13A5 IN 1